A partial form of AIRE deficiency underlies a mild form of autoimmune polyendocrine syndrome type 1

Bergithe Eikeland Oftedal, Amund Holte Berger, Øyvind Bruserud, Yael Goldfarb, Andre Sulen, Lars Breivik, Alexander Hellesen, Shifra Ben-Dor, Rebecca Haffner-Krausz, Per M. Knappskog, Stefan Johansson, Anette S.B. Wolff, Eirik Bratland, Jakub Abramson, Eystein Sverre Husebye

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Autoimmune polyendocrine syndrome type 1 (APS-1) is caused by mutations in the autoimmune regulator (AIRE) gene. Most patients present with severe chronic mucocutaneous candidiasis and organ-specific autoimmunity from early childhood, but the clinical picture is highly variable. AIRE is crucial for negative selection of T cells, and scrutiny of different patient mutations has previously highlighted many of its molecular mechanisms. In patients with a milder adult-onset phenotype sharing a mutation in the canonical donor splice site of intron 7 (c.879+1G>A), both the predicted altered splicing pattern with loss of exon 7 (AireEx7–/–) and normal full-length AIRE mRNA were found, indicating leaky rather than abolished mRNA splicing. Analysis of a corresponding mouse model demonstrated that the AireEx7–/– mutant had dramatically impaired transcriptional capacity of tissue-specific antigens in medullary thymic epithelial cells but still retained some ability to induce gene expression compared with the complete loss-of-function AireC313X–/– mutant. Our data illustrate an association between AIRE activity and the severity of autoimmune disease, with implications for more common autoimmune diseases associated with AIRE variants, such as primary adrenal insufficiency, pernicious anemia, type 1 diabetes, and rheumatoid arthritis.
Original languageEnglish
Article numbere169704
JournalThe Journal of Clinical Investigation
Volume133
Issue number21
DOIs
Publication statusPublished - 1 Nov 2023

Bibliographical note

We highly appreciate the technical assistance of Hajirah Muneer, Elin Theodorsen, Marie Karlsen, and Elisabeth Tombra Halvorsen (all from Haukeland University Hospital, Bergen, Norway); Brith Bergum at the Flow Cytometry Section, Core Facilities, Department of Clinical Science, University of Bergen; and Endy Spriet at the Molecular Imaging Center, Core Facilities, Department of Biomedicine, University of Bergen. The Genomics Core Facility (GCF) at the University of Bergen, which is a part of the NorSeq Consortium, provided RNA-Seq services. GCF is supported in part by major grants from the Research Council of Norway (grant no. 245979/F50), Trond Mohn Stiftelse (grant no. BFS2016-genom), and the Bergen Research Foundation (BFS) (grant no. BFS2017TMT04 and BFS2017TMT08). This study was supported by grants from the University of Bergen, the Bergen Research Foundation, Stiftelsen KG Jebsen, and the Regional Health Authorities of Western Norway. BEO received grant funding from the Research Council of Norway (grant no. 250030), the Regional Health Authorities of Western Norway, and the Novo Nordisk Foundation (grant no. 103302). AHB received a project grant from the Meltzer Research Fund.

Fingerprint

Dive into the research topics of 'A partial form of AIRE deficiency underlies a mild form of autoimmune polyendocrine syndrome type 1'. Together they form a unique fingerprint.

Cite this